​

Health Catalyst (HCAT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HCAT Stock Forecast

Health Catalyst (HCAT) stock forecast, based on 20 Wall Street analysts, predicts a 12-month average price target of $5.67, with a high of $7.00 and a low of $5.00. This represents a 51.20% increase from the last price of $3.75.

$3 $4 $5 $6 $7 $8 $9 $10 High: $7 Avg: $5.67 Low: $5 Last Closed Price: $3.75

HCAT Stock Rating

Health Catalyst stock's rating consensus is Buy, based on 20 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (85.00%), 3 Hold (15.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 20 0 3 17 Strong Sell Sell Hold Buy Strong Buy

HCAT Price Target Upside V Benchmarks

TypeNameUpside
StockHealth Catalyst51.20%
SectorHealthcare Stocks 35.25%
IndustryHealthcare Information Services Stocks 36.10%

Price Target Trends

1M3M12M
# Anlaysts127
Avg Price Target$5.00$5.00$8.57
Last Closing Price$3.75$3.75$3.75
Upside/Downside33.33%33.33%128.53%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25283--13
Mar, 25284--14
Feb, 25284--14
Jan, 25285--15
Dec, 24375--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 16, 2025Scott SchoenhausKeyBanc$5.00$3.7533.33%33.33%
Mar 06, 2025Stephens$5.00$4.4312.87%33.33%
Jan 14, 2025Sean DodgeRBC Capital$7.00$6.980.29%86.67%
Sep 03, 2024Richard CloseCanaccord Genuity$11.00$7.2950.89%193.33%
Aug 26, 2024Jessica TassanPiper Sandler$11.00$7.1952.99%193.33%
Aug 08, 2024Jeff GarroStephens$7.00$5.4827.74%86.67%
Jun 06, 2024Jessica TassanPiper Sandler$14.00$6.70108.96%273.33%
Jan 26, 2024Jack WallaceGuggenheim$14.00$9.9440.85%273.33%
May 11, 2022Jessica TassanPiper Sandler$21.00$12.9562.16%460.00%
Mar 02, 2022Sean DodgeRBC Capital$35.00$27.5427.09%833.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 16, 2025KeyBancOverweightOverweighthold
Jan 14, 2025RBC CapitalSector PerformSector Performhold
Oct 08, 2024Evercore ISIOutperformOutperformhold
Sep 20, 2024StephensEqual-WeightEqual-Weighthold
Sep 03, 2024Canaccord GenuityBuyBuyhold
Aug 26, 2024Piper SandlerOverweightOverweighthold
Aug 09, 2024StephensBuyBuyhold
Aug 08, 2024StephensEqual-WeightEqual-Weighthold
Jul 09, 2024Wells FargoBuyBuyhold
Jul 01, 2024Wells FargoOverweightOverweighthold

Financial Forecast

EPS Forecast

$-4 $-3 $-2 $-1 $0 $1 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.91$-3.23$-2.56$-2.09$-1.15----
Avg Forecast$-0.73$-0.50$-0.34$0.15$0.31$0.38$0.54$-0.33-
High Forecast$-0.72$-0.49$-0.33$0.18$0.37$0.50$0.80$-0.32-
Low Forecast$-0.73$-0.50$-0.34$0.02$0.27$0.17$0.28$-0.34-
Surprise %298.63%546.00%652.94%-1493.33%-470.97%----

Revenue Forecast

$150M $230M $310M $390M $470M $550M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$188.84M$241.93M$276.24M$295.94M$306.58M----
Avg Forecast$187.65M$240.34M$275.40M$294.47M$306.64M$337.13M$370.21M$407.91M$495.90M
High Forecast$189.27M$242.42M$278.54M$295.31M$307.44M$342.58M$370.60M$412.30M$506.23M
Low Forecast$186.36M$238.69M$272.79M$293.68M$305.51M$331.81M$369.82M$403.51M$490.08M
Surprise %0.64%0.66%0.31%0.50%-0.02%----

Net Income Forecast

$-200M $-150M $-100M $-50M $0 $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-115.02M$-153.21M$-137.40M$-118.15M$-69.50M----
Avg Forecast$-93.07M$-28.14M$-126.22M$-118.15M$17.93M$18.73M$30.52M$-18.62M-
High Forecast$-74.45M$-27.89M$-100.97M$-94.52M$20.87M$28.09M$45.38M$-18.33M-
Low Forecast$-111.68M$-28.46M$-151.46M$-141.78M$14.99M$9.36M$15.65M$-19.12M-
Surprise %23.59%444.37%8.86%--487.61%----

HCAT Forecast FAQ

Is Health Catalyst stock a buy?

Health Catalyst stock has a consensus rating of Buy, based on 20 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Health Catalyst is a favorable investment for most analysts.

What is Health Catalyst's price target?

Health Catalyst's price target, set by 20 Wall Street analysts, averages $5.67 over the next 12 months. The price target range spans from $5 at the low end to $7 at the high end, suggesting a potential 51.20% change from the previous closing price of $3.75.

How does Health Catalyst stock forecast compare to its benchmarks?

Health Catalyst's stock forecast shows a 51.20% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the healthcare information services stocks industry (36.10%).

What is the breakdown of analyst ratings for Health Catalyst over the past three months?

  • April 2025: 15.38% Strong Buy, 61.54% Buy, 23.08% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 14.29% Strong Buy, 57.14% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 14.29% Strong Buy, 57.14% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.

What is Health Catalyst’s EPS forecast?

Health Catalyst's average annual EPS forecast for its fiscal year ending in December 2025 is $0.38, marking a -133.04% decrease from the reported $-1.15 in 2024. Estimates for the following years are $0.54 in 2026, $-0.33 in 2027, and $0 in 2028.

What is Health Catalyst’s revenue forecast?

Health Catalyst's average annual revenue forecast for its fiscal year ending in December 2025 is $337.13M, reflecting a 9.96% increase from the reported $306.58M in 2024. The forecast for 2026 is $370.21M, followed by $407.91M for 2027, and $495.9M for 2028.

What is Health Catalyst’s net income forecast?

Health Catalyst's net income forecast for the fiscal year ending in December 2025 stands at $18.73M, representing a -126.95% decrease from the reported $-69.502M in 2024. Projections indicate $30.52M in 2026, $-18.618M in 2027, and $0 in 2028.